Market Place
Sourcing Support
Achieve Life Sciences Reports Q2 2024 Results And Corporate Update
13 Aug 2024 //
GLOBENEWSWIRE
Achieve Publishes Cytisinicline Vaping Cessation Trial In JAMA
06 May 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Cytisinicline ORCA Program to be Presented at 2024(SRNT)
20 Mar 2024 //
GLOBENEWSWIRE
Achieve Life presents positive data from ph3 ORCA-2 trial of cytisinicline
06 Mar 2023 //
PHARMABIZ
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline
21 Dec 2022 //
GLOBENEWSWIRE
Achieve Reports Financial Results for 3Qr 2022 and Provides Corporate Update
14 Nov 2022 //
GLOBENEWSWIRE
Achieve Announces Early Completion of Enrollment Cytisinicline e-Cigarette Trial
08 Nov 2022 //
GLOBENEWSWIRE
Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial
27 Sep 2022 //
GLOBENEWSWIRE
Achieve Life Sciences Initiates PII ORCA-V1 Trial Evaluating Cytisinicline
29 Jun 2022 //
GLOBENEWSWIRE
Achieve Life Sciences Awarded Grant from NIH for PII Trial of Cytisinicline
01 Jun 2022 //
GLOBENEWSWIRE
Achieve Life Sciences Awarded Grant from NIH for PII Trial of Cytisinicline
01 Jun 2022 //
TRIALSITENEWS
Achieve Life Sciences Expands Clinical Ops. Team; Granting of Inducement Award
03 Feb 2022 //
GLOBENEWSWIRE
Achieve Life Sciences Initiates Phase 3 ORCA-3 Trial Evaluating Cytisinicline
25 Jan 2022 //
GLOBENEWSWIRE
Achieve LS Completes Last Subject, Last Follow-Up Visit in Phase 3 ORCA-2 Trial
04 Jan 2022 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Phase 3 ORCA-2 Trial of Cytisinicline
22 Nov 2021 //
GLOBENEWSWIRE
Achieve Life Sciences Presentation of Cytisinicline Data at (SRNT-E) Conference
14 Sep 2021 //
YAHOO
Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing
11 Aug 2021 //
PRESS RELEASE
Cytisine vs Varenicline for Smoking Cessation: Results From a Noninferiority Trial
03 Aug 2021 //
MEDICAL.BAG
Achieve Announces Enrollment of 750 Subjects in Phase 3 ORCA-2 Trial
29 Jun 2021 //
BIOSPACE
Lilly Reveals Critical Barriers to Optimal Migraine Care & Insights From Novel
03 Jun 2021 //
PRNEWSWIRE
Achieve Announces Publication of the ORCA-1 Ph2b Clinical Trial of Cytisinicline
14 Apr 2021 //
BIOSPACE
Achieve Announces Publication of the RAUORA Head-to-Head Non-Inferiorit
25 Mar 2021 //
BIOSPACE
Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial
07 Oct 2020 //
PRNEWSWIRE
Achieve Life Announces Results from Evaluation of Cytisinicline versus Chantix®
18 Sep 2020 //
BIOSPACE
Achieve Announces Patent Granted in the U.S. for Novel Analogs of Cytisinicline
31 Jul 2020 //
PRNEWSWIRE
Achieve Announces Successful Results from the Investigator-Initiated RAUORA
29 Jun 2020 //
PRNEWSWIRE
Achieve Receives $4.2 Million from Exercise of Warrants
04 Jun 2019 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.